A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Blood Pressure
Cardiovascular Fixed Dose Combination Pill: A Pharmacodynamic Interaction Study to Evaluate the Effect of a Fixed Dose Combination of Acetylsalicylic Acid, Simvastatin and Ramipril (Cardiovascular Fixed Dose Combination Pill) on Blood Pressure
Sponsor: Ferrer Internacional S.A.
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from Ferrer Internacional S.A.
- Amyotrophic Lateral Sclerosis · Phase PHASE3 · Feb 2024
- Compensated Heart Failure · Phase PHASE4 · Dec 2012
- Elevated LDL Cholesterol · Phase PHASE2 · Apr 2012
- Acute Stroke · Phase PHASE3 · Mar 2012
- Dermatomycoses · Phase PHASE4 · Nov 2011
More terminations from Ferrer Internacional S.A.
Listed as NCT01005290, this PHASE2 trial focuses on Hypertension and remains terminated or withdrawn. Sponsored by Ferrer Internacional S.A., it has been updated 9 times since 2009, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE2
-
Dec 2021 — Dec 2022 [monthly]
Terminated PHASE2
▶ Show 4 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE2
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE2
First recorded
Oct 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ferrer Internacional S.A.
For direct contact, visit the study record on ClinicalTrials.gov .